Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
Abstract Pancreatic beta cells undergo compensatory proliferation in the early phase of type 2 diabetes. While pathways such as FoxM1 are involved in regulating compensatory beta cell proliferation, given the lack of therapeutics effectively targeting beta cell proliferation, other targetable pathwa...
Saved in:
| Main Authors: | Jian Ma, Bowen Xing, Yan Cao, Xin He, Kate E Bennett, Chao Tong, Chiying An, Taylor Hojnacki, Zijie Feng, Sunbin Deng, Sunbin Ling, Gengchen Xie, Yuan Wu, Yue Ren, Ming Yu, Bryson W Katona, Hongzhe Li, Ali Naji, Xianxin Hua |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-04-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202013524 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PDZ Binding Kinase (PBK) Immunoexpression in Invasive Pituitary Adenomas: An Exploratory Study
by: Shilpa Rao, et al. -
Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
by: Bingxin Li, et al.
Published: (2025-04-01) -
Menin inhibitors from monotherapies to combination therapies: clinical trial updates from 2024 ASH annual meeting
by: Gejia Cao, et al.
Published: (2025-06-01) -
Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma
by: Shen Tian, et al.
Published: (2025-02-01) -
MENIN inhibitor-based therapy in acute leukemia: latest updates from the 2024 ASH annual meeting
by: Jiewen Sun, et al.
Published: (2025-05-01)